CliffBio
small molecule

CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER

NICARDIPINE HYDROCHLORIDE

Loss of exclusivityDecember 2027latest FDA-listed patent expiry
CompanyChiesi Usa, Inc. →View the full company profile on CliffBio

Drug detail

Brand nameCARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER
Active ingredientNICARDIPINE HYDROCHLORIDE
Strength20MG/200ML (0.1MG/ML)
Dosage formINJECTABLE
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalJuly 2008
Marketing statusRX

Listed patents

PatentExpiresType
9364564December 2027product
7612102December 2027product
7659291April 2027use U-1029
8455524April 2027use U-1029
11547758April 2027use U-1029
10758616April 2027product

More from Chiesi Usa, Inc.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER patent cliff — loss of exclusivity December 2027 | CliffBio